send mail to email@example.com mentioning your email id and mobileno registered with us! if details not recieved
Resend Opt after 60 Sec.
Please verify your mobile number
Refer & Earn
My Abhipedia Earning
Kindly Login to view your earning
According to World Health Organisation (WHO), additional clarifications from manufacturer are required to conduct final Emergency Use Listing (EUL) risk-benefit assessment for using Bharat Biotech’s Covaxin globally.
Technical Advisory Group for Emergency Use Listing (TAG-EUL)
TAG-EUL is an independent advisory group. It provides recommendations on whether Covid 19 vaccine can be listed for emergency use or not under the EUL procedure. It submits report to WHO.
Covaxin is the first indigenous COVID-19 vaccine of India. It is developed by Hyderabad-based Bharat Biotech in association with Indian Council of Medical Research (ICMR). The vaccine is 77.8 per cent effective against symptomatic covid-19 while 65.2 per cent against Delta variant. It is an inactivated virus-based covid-19 vaccine
By: Brijesh Kumar ProfileResourcesReport error
Access to prime resources